NZ595223A - Combinations including pneumococcal serotype 14 saccharide - Google Patents
Combinations including pneumococcal serotype 14 saccharideInfo
- Publication number
- NZ595223A NZ595223A NZ595223A NZ59522310A NZ595223A NZ 595223 A NZ595223 A NZ 595223A NZ 595223 A NZ595223 A NZ 595223A NZ 59522310 A NZ59522310 A NZ 59522310A NZ 595223 A NZ595223 A NZ 595223A
- Authority
- NZ
- New Zealand
- Prior art keywords
- saccharide
- pneumococcal serotype
- combinations including
- including pneumococcal
- los
- Prior art date
Links
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- IEQCXFNWPAHHQR-YKLSGRGUSA-N beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O IEQCXFNWPAHHQR-YKLSGRGUSA-N 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 1
- 150000004044 tetrasaccharides Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16299609P | 2009-03-24 | 2009-03-24 | |
| PCT/IB2010/000735 WO2010109325A2 (en) | 2009-03-24 | 2010-03-24 | Combinations including pneumococcal serotype 14 saccharide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ595223A true NZ595223A (en) | 2013-12-20 |
Family
ID=42352288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ595223A NZ595223A (en) | 2009-03-24 | 2010-03-24 | Combinations including pneumococcal serotype 14 saccharide |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120064104A1 (enExample) |
| EP (1) | EP2411044A2 (enExample) |
| JP (2) | JP5806204B2 (enExample) |
| CN (1) | CN102421449A (enExample) |
| AU (1) | AU2010227221B2 (enExample) |
| CA (1) | CA2756398A1 (enExample) |
| NZ (1) | NZ595223A (enExample) |
| RU (2) | RU2549438C2 (enExample) |
| WO (1) | WO2010109325A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1179072A2 (en) | 1999-05-19 | 2002-02-13 | Chiron S.P.A. | Combination neisserial compositions |
| GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
| KR20140033127A (ko) | 2011-05-17 | 2014-03-17 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 스트렙토코쿠스 뉴모니애에 대한 백신 |
| CN104428008B (zh) | 2012-05-24 | 2020-10-09 | 美国政府(由卫生和人类服务部的部长所代表) | 多价脑膜炎球菌缀合物及制备缀合物的方法 |
| ES2847923T3 (es) * | 2012-06-14 | 2021-08-04 | Glaxosmithkline Biologicals Sa | Vacunas contra el meningococo del serogrupo X |
| CN104736563A (zh) | 2012-07-27 | 2015-06-24 | 国家健康与医学研究院 | Cd147作为受体用于脑膜炎球菌至血管内皮的菌毛介导的粘附 |
| IL312327B2 (en) * | 2014-01-21 | 2026-02-01 | Pfizer | Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses |
| US20150344530A1 (en) * | 2014-05-29 | 2015-12-03 | Subhash V. Kapre | Synthetic Peptides as Carriers for Conjugation with Polysaccharides |
| US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| WO2023132795A2 (en) * | 2022-01-05 | 2023-07-13 | National University Of Singapore | Modified bacterial glycans and conjugates thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1674933B (zh) * | 2002-08-02 | 2012-09-26 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗组合物 |
| JP5792920B2 (ja) * | 2005-12-22 | 2015-10-14 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
-
2010
- 2010-03-24 WO PCT/IB2010/000735 patent/WO2010109325A2/en not_active Ceased
- 2010-03-24 RU RU2011142747/15A patent/RU2549438C2/ru not_active IP Right Cessation
- 2010-03-24 CA CA2756398A patent/CA2756398A1/en not_active Abandoned
- 2010-03-24 NZ NZ595223A patent/NZ595223A/en not_active IP Right Cessation
- 2010-03-24 US US13/260,550 patent/US20120064104A1/en not_active Abandoned
- 2010-03-24 CN CN2010800212325A patent/CN102421449A/zh active Pending
- 2010-03-24 AU AU2010227221A patent/AU2010227221B2/en not_active Ceased
- 2010-03-24 EP EP10714681A patent/EP2411044A2/en not_active Withdrawn
- 2010-03-24 JP JP2012501410A patent/JP5806204B2/ja not_active Expired - Fee Related
-
2014
- 2014-05-30 RU RU2014122163/15A patent/RU2014122163A/ru not_active Application Discontinuation
-
2015
- 2015-06-17 JP JP2015121897A patent/JP2015163651A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN102421449A (zh) | 2012-04-18 |
| JP2015163651A (ja) | 2015-09-10 |
| JP5806204B2 (ja) | 2015-11-10 |
| RU2011142747A (ru) | 2013-04-27 |
| WO2010109325A3 (en) | 2011-01-20 |
| US20120064104A1 (en) | 2012-03-15 |
| CA2756398A1 (en) | 2010-09-30 |
| EP2411044A2 (en) | 2012-02-01 |
| RU2549438C2 (ru) | 2015-04-27 |
| AU2010227221A1 (en) | 2011-10-13 |
| RU2014122163A (ru) | 2015-12-10 |
| JP2012521404A (ja) | 2012-09-13 |
| WO2010109325A2 (en) | 2010-09-30 |
| AU2010227221B2 (en) | 2015-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL222346A (en) | An immunogenic preparation containing at least two capsular sugars of meningitides n, its use and a vaccine containing it | |
| AR130928A2 (es) | Composición inmunogénica | |
| IL227934A (en) | An immunogenic preparation containing polysaccharide or oligosaccharide from s. type 5 or 8 aureus and various aspects related to it | |
| HRP20190037T1 (hr) | Cjepivo na bazi konjugata pneumokoknih polisaharida | |
| MX2012004551A (es) | Nuevas composiciones para prevenir y/o tratar trastornos de almacenamiento lisosomal. | |
| WO2008053444A3 (en) | Treating a respiratory condition with bifidobacterium | |
| MX389480B (es) | Vacuna conjugada neumococica polivalente. | |
| CA2861995C (en) | Oral product comprising a mouth-stable polymer matrix and fibers | |
| SG10201406432RA (en) | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions | |
| PT1777236T (pt) | Sacáridos modificados possuindo estabilidade melhorada em água para utilização como um medicamento | |
| WO2008020322A3 (en) | Combination vaccines with 1-hydroxy-2-phenoxyethane preservative | |
| PH12015501309A1 (en) | Human milk oligosaccharides to ameliorate symptoms of stress | |
| EP2023926A4 (en) | PYRIDONECARBOXAMIDE DERIVATIVES USEFUL FOR TREATING HYPERPROLIFERATIVE AND ANGIOGENESIS RELATED DISORDERS | |
| MX341778B (es) | Goma de mascar natural incluyendo materiales de celulosa. | |
| WO2007116028A3 (en) | Conjugate vaccines | |
| IN2009KN04098A (enExample) | ||
| WO2009027594A3 (fr) | Verres bioactifs dopes en strontium | |
| WO2008033300A8 (en) | Bis (thiohydrazide amides) formulation | |
| WO2012115467A3 (en) | Laundry treatment apparatus | |
| WO2007124855A8 (de) | Antiseptikahaltige silikonelastomere | |
| IN2014DN09791A (enExample) | ||
| WO2013160349A3 (en) | Cosmetic composition comprising a phosphorylated oligosaccharide and a polysaccharide | |
| HK1217642A1 (zh) | 合成用於绿脓杆菌疫苗的低聚糖 | |
| HK1211795A1 (en) | Synthetic oligosaccharides for p. aeruginosa vaccine | |
| WO2009032978A3 (en) | Compositions and methods for diagnosing and treating urinary tract infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 24 MAR 2017 BY FB RICE Effective date: 20140327 |
|
| ERR | Error or correction |
Free format text: THE OWNER HAS BEEN CORRECTED TO 890887, NOVARTIS AG, LICHTSTRASSE 35, CH-4056 BASEL, CH Effective date: 20140409 |
|
| LAPS | Patent lapsed |